269 related articles for article (PubMed ID: 34525848)
1. Potentially inappropriate prescriptions of antipsychotic and anticholinergic drugs in patients with Parkinson's disease.
Valladales-Restrepo LF; Peña-Verjan NM; Vargas-Díaz K; Machado-Alba JE
Neurodegener Dis Manag; 2021 Oct; 11(5):361-371. PubMed ID: 34525848
[TBL] [Abstract][Full Text] [Related]
2. The use and potential abuse of anticholinergic antiparkinson drugs in Norway: a pharmacoepidemiological study.
Gjerden P; Bramness JG; Slørdal L
Br J Clin Pharmacol; 2009 Feb; 67(2):228-33. PubMed ID: 19094158
[TBL] [Abstract][Full Text] [Related]
3. Features of anticholinergic prescriptions and predictors of high use in the elderly: Population-based study.
Joung KI; Shin JY; Cho SI
Pharmacoepidemiol Drug Saf; 2019 Dec; 28(12):1591-1600. PubMed ID: 31692168
[TBL] [Abstract][Full Text] [Related]
4. Anticholinergic burden in Parkinson's disease inpatients.
Lertxundi U; Isla A; Solinis MA; Domingo-Echaburu S; Hernandez R; Peral-Aguirregoitia J; Medrano J
Eur J Clin Pharmacol; 2015 Oct; 71(10):1271-7. PubMed ID: 26254777
[TBL] [Abstract][Full Text] [Related]
5. Potentially Inappropriate Prescriptions for Anticholinergic Medications for Patients with Constipation.
Valladales-Restrepo LF; Paredes-Mendoza M; Machado-Alba JE
Dig Dis; 2020; 38(6):500-506. PubMed ID: 32135532
[TBL] [Abstract][Full Text] [Related]
6. Potentially inappropriate prescriptions of anticholinergic drugs in patients with benign prostatic hyperplasia.
Valladales-Restrepo LF; Machado-Alba JE
Aging Male; 2020 Dec; 23(5):785-792. PubMed ID: 30955405
[TBL] [Abstract][Full Text] [Related]
7. Prescription patterns of anticholinergic agents and their associated factors in Korean elderly patients with dementia.
Lee EK; Lee YJ
Int J Clin Pharm; 2013 Oct; 35(5):711-8. PubMed ID: 23708883
[TBL] [Abstract][Full Text] [Related]
8. Antipsychotic Prescribing Practices in Those with Parkinsonism: Adherence to Guidelines.
Rigby HB; Rehan S; Hill-Taylor B; Matheson K; Sketris I
Can J Neurol Sci; 2017 Sep; 44(5):603-606. PubMed ID: 28478793
[TBL] [Abstract][Full Text] [Related]
9. Potentially Inappropriate Medications Pre- and Post-Diagnosis of Major Neurocognitive Disorders Among Older People in Sweden: A Register-Based, 6-Year Longitudinal Study.
Sönnerstam E; Gustafsson M; Lövheim H; Sjölander M
Drugs Aging; 2022 Jul; 39(7):573-585. PubMed ID: 35655061
[TBL] [Abstract][Full Text] [Related]
10. Using antipsychotic agents in older patients.
Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
[TBL] [Abstract][Full Text] [Related]
11. Prescription of potentially inappropriate medications among older people with intellectual disability: a register study.
Axmon A; Sandberg M; Ahlström G; Midlöv P
BMC Pharmacol Toxicol; 2017 Oct; 18(1):68. PubMed ID: 29070067
[TBL] [Abstract][Full Text] [Related]
12. Potentially inappropriate prescriptions of anticholinergic medications in patients with closed-angle glaucoma.
Valladales-Restrepo LF; Machado-Alba JE
Int Ophthalmol; 2020 Apr; 40(4):803-809. PubMed ID: 31792854
[TBL] [Abstract][Full Text] [Related]
13. Association between Anticholinergic Medication Use and Risk of Dementia among Patients with Parkinson's Disease.
Sheu JJ; Tsai MT; Erickson SR; Wu CH
Pharmacotherapy; 2019 Aug; 39(8):798-808. PubMed ID: 31251824
[TBL] [Abstract][Full Text] [Related]
14. Potentially inappropriate prescriptions of anticholinergics drugs in Alzheimer's disease patients.
Valladales-Restrepo LF; Duran-Lengua M; Machado-Alba JE
Geriatr Gerontol Int; 2019 Sep; 19(9):913-917. PubMed ID: 31342625
[TBL] [Abstract][Full Text] [Related]
15. Inappropriate anticholinergic drugs prescriptions in older patients: analysing a hospital database.
Ferret L; Ficheur G; Delaviez E; Luyckx M; Quenton S; Beuscart R; Chazard E; Beuscart JB
Int J Clin Pharm; 2018 Feb; 40(1):94-100. PubMed ID: 29147963
[TBL] [Abstract][Full Text] [Related]
16. Potentially inappropriate anticholinergic medication use in community-dwelling older adults: a national cross-sectional study.
Kachru N; Carnahan RM; Johnson ML; Aparasu RR
Drugs Aging; 2015 May; 32(5):379-89. PubMed ID: 25832970
[TBL] [Abstract][Full Text] [Related]
17. Incidence, prescription patterns, and determinants of antipsychotic use in patients with Parkinson's disease.
Wang MT; Lian PW; Yeh CB; Yen CH; Ma KH; Chan AL
Mov Disord; 2011 Aug; 26(9):1663-9. PubMed ID: 21630354
[TBL] [Abstract][Full Text] [Related]
18. [Detecting and assessing the impactof anticholinergic medications].
Csajka C; Brémond C; Lang PO
Rev Med Suisse; 2017 Nov; 13(582):1931-1937. PubMed ID: 29120540
[TBL] [Abstract][Full Text] [Related]
19. Treatment of psychosis in Parkinson's disease: safety considerations.
Fernandez HH; Trieschmann ME; Friedman JH
Drug Saf; 2003; 26(9):643-59. PubMed ID: 12814332
[TBL] [Abstract][Full Text] [Related]
20. [Anticholinergic scales: Use in psychiatry and update of the anticholinergic impregnation scale].
Javelot H; Meyer G; Becker G; Post G; Runge V; Pospieszynski P; Schneiderlin T; Armand-Branger S; Michel B; Weiner L; Faria CGF; Drapier D; Fakra E; Fossati P; Haffen E; Yrondi A; Hingray C
Encephale; 2022 Jun; 48(3):313-324. PubMed ID: 34876278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
